Internal Medicine, Rheumatology · Glendale, CA
NPI
1952460859
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
435 Arden Ave Ste 510
Glendale, CA, 91203
Phone (818) 243-1187
Groups this clinician bills Medicare through
Medicare paid, 2024
$762K
29,949 services
Medicare patients, 2024
1,355
Average age 75
Drug cost, 2024
$10.0M
9,928 prescriptions
Company payments, 2025
$2,970
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Noune Pashinian was code J1010 (injection, methylprednisolone acetate, 1 mg), 6,751 times for 238 patients. In total Noune Pashinian billed 29,949 services in 40 codes, and Medicare paid $762K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-04-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 6,751 | 238 | $0.10 | $687 |
| J7325 Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | Office | 6,277 | 93 | $7.02 | $44K |
| J0897 Injection, denosumab, 1 mg | Office | 5,040 | 54 | $20.74 | $105K |
| 99213 Office E&M - Established | Office | 3,212 | 1,151 | $67.16 | $216K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 1,953 | 377 | $0.74 | $1,455 |
| 36415 Venipuncture Blood Collection | Office | 905 | 560 | $8.65 | $7,828 |
| 20611 Joint Injection | Office | 863 | 443 | $81.24 | $70K |
| 77080 Standard X-ray | Office | 854 | 847 | $40.15 | $34K |
| 96401 Chemotherapy Administration | Office | 688 | 423 | $57.55 | $40K |
| J7324 Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | Office | 497 | 172 | $97.90 | $49K |
| 96372 Injection Administration | Office | 479 | 163 | $11.19 | $5,359 |
| 99204 Office E&M - New | Office | 409 | 409 | $123.74 | $51K |
| 99214 Office E&M - Established | Office | 385 | 303 | $92.83 | $36K |
| 76882 Ultrasound - Nonspecific | Office | 213 | 193 | $49.85 | $11K |
| 76942 Ultrasound - Nonspecific | Office | 146 | 125 | $45.82 | $6,690 |
By year: 2022 $794K for 30,982 services; 2023 $697K for 20,241 services; 2024 $762K for 29,949 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 905 | 560 | $8.65 | $7,828 |
Medicare prescription drug claims, 2024
In 2024, the drug Noune Pashinian prescribed most often to Medicare patients was Methotrexate (Methotrexate Sodium), with 1,259 prescriptions and refills. In total Noune Pashinian wrote 9,928 Medicare prescriptions that cost $10.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Methotrexate Methotrexate Sodium | 1,259 | 1,670 | 200 | $20K |
| Meloxicam Generic | 633 | 727 | 169 | $1,052 |
| Gabapentin Generic | 630 | 708 | 148 | $2,604 |
| Prolia Denosumab | 559 | 3,354 | 381 | $905K |
| Prednisone Generic | 555 | 708 | 141 | $2,507 |
| Hydroxychloroquine Sulfate Generic | 543 | 706 | 82 | $10K |
| Enbrel Sureclick Etanercept | 227 | 229 | 30 | $1.7M |
| Leflunomide Generic | 193 | 235 | 30 | $6,515 |
| Humira(Cf) Pen Adalimumab | 191 | 198 | 26 | $1.5M |
| Diclofenac Sodium Generic | 180 | 209 | 39 | $42K |
| Duloxetine Hcl Generic | 172 | 205 | 40 | $2,939 |
| Alendronate Sodium Generic | 154 | 196 | 29 | $425 |
| Escitalopram Oxalate Generic | 147 | 173 | 19 | $827 |
| Tramadol Hcl Generic | 144 | 146 | 36 | $460 |
| Baclofen Generic | 142 | 144 | 49 | $371 |
Brand drugs: 2,251 claims; generic drugs: 7,630 claims; opioid claims: 214.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Noune Pashinian $2,970 ($2,970 in general payments such as food, travel and fees) from 14 companies. The largest payer was Abbvie Inc. with $998.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 43 | $998 |
| Lilly USA, LLC LLY | 10 | $306 |
| Novartis Pharmaceuticals Corporation NVS | 14 | $266 |
| Janssen Biotech, Inc. JNJ | 8 | $257 |
| Pfizer Inc. PFE | 7 | $227 |
| GlaxoSmithKline, LLC. GSK | 11 | $212 |
| UCB, Inc. UCB.BR | 6 | $164 |
| Amgen Inc. AMGN | 7 | $158 |
| Aurinia Pharma U.S., Inc. AUPH | 5 | $116 |
| Alexion Pharmaceuticals, Inc. AZN | 4 | $94.32 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.